Ealixir, Inc.
EAXR · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | – | $0 |
| % Growth | -35% | – | – | – |
| Cost of Goods Sold | $0 | $0 | – | $0 |
| Gross Profit | $1 | $1 | – | $0 |
| % Margin | 93.7% | 91.8% | – | 35.4% |
| R&D Expenses | $0 | $0 | – | $0 |
| G&A Expenses | $0 | $0 | – | $0 |
| SG&A Expenses | $1 | $1 | – | $1 |
| Sales & Mktg Exp. | $0 | $0 | – | $0 |
| Other Operating Expenses | $0 | $0 | – | $0 |
| Operating Expenses | $1 | $1 | – | $1 |
| Operating Income | $0 | $0 | – | -$1 |
| % Margin | 10.2% | 4.1% | – | -268.9% |
| Other Income/Exp. Net | -$0 | $0 | – | -$0 |
| Pre-Tax Income | $0 | $0 | – | -$1 |
| Tax Expense | $0 | $0 | – | -$0 |
| Net Income | $0 | $0 | – | -$1 |
| % Margin | 6.4% | 0% | – | -237.1% |
| EPS | 0 | 0 | – | -0.011 |
| % Growth | -100% | – | – | – |
| EPS Diluted | 0 | 0 | – | -0.011 |
| Weighted Avg Shares Out | 60 | 60 | – | 60 |
| Weighted Avg Shares Out Dil | 60 | 60 | – | 60 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | – | $0 |
| Interest Expense | $0 | $0 | – | $0 |
| Depreciation & Amortization | $0 | $0 | – | $0 |
| EBITDA | $0 | $0 | – | -$1 |
| % Margin | 8% | 5.8% | – | -254.3% |